These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3773232)

  • 1. Beneficial effect of OPC-8212 (3,4-dihydro-6-(4-(3,4-dimethoxy benzoyl)-1-piperazinyl)-2(1H)-quinolinone on myocardial oxygen consumption in dogs with ischemic heart failure.
    Hori M; Inoue M; Tamai J; Koretsune Y; Kitakaze M; Iwai K; Iwakura K; KitabatakeA ; Kamada T
    Jpn Circ J; 1986 Jul; 50(7):659-66. PubMed ID: 3773232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.
    Inoue M; Hori M; Nakajima S; Kitakaze M; Fukunami M; Ishida Y; Abe H
    Arzneimittelforschung; 1984; 34(3A):355-9. PubMed ID: 6540088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotonic activity of a new inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in the dog with and without beta-blocker and Ca++-antagonist pretreatment.
    Hori M; Inoue M; Tamai J; Koretsune Y; Kitakaze M; Iwai K; Ito H; Kitabatake A; Kamada T
    Jpn Circ J; 1986 Jan; 50(1):37-44. PubMed ID: 3702034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and electrophysiological effects of a novel positive inotropic drug, OPC-8212, in normal and "failing" guinea pig heart preparations.
    Grupp G; Grupp IL; Kojima M; Sperelakis N; Tsuchiya Y; Hosokawa T; Schwartz A
    J Cardiovasc Pharmacol; 1986; 8(2):428-40. PubMed ID: 2422485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.
    Greenberg S; Touhey B; Paul J
    Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in conscious and anesthetized dogs.
    Miyazaki S; Sasayama S; Nakamura Y; Kihara Y; Susawa T; Kawai C
    J Cardiovasc Pharmacol; 1986; 8(1):14-20. PubMed ID: 2419676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of OPC-8212 (2(1H)-quinolinone), a new inotropic agent, on myocardial energy metabolism in patients with coronary heart disease.
    Nanto S; Kodama K; Kimura Y; Masuyama T; Mishima M; Hamanaka Y; Hori M; Inoue M
    Jpn Circ J; 1988 Feb; 52(2):155-61. PubMed ID: 3361701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart.
    Kirk ES; LeJemtel TH; Nelson GR; Sonnenblick EH
    Am J Med; 1978 Jul; 65(1):189-96. PubMed ID: 685993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
    Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride(OPC-1085) on coronary circulation and myocardial metabolism].
    Takenaka F; Shintani S; Ishihara T; Higuchi M; Hiraki I
    Nihon Yakurigaku Zasshi; 1975 Mar; 71(2):221-30. PubMed ID: 1093960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent.
    Greenberg S; Touhey B
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of OPC-8212, a new positive inotropic agent, and dobutamine on left ventricular global and ischemic regional functions and coronary hemodynamics under coronary artery stenosis.
    Maruyama Y; Nishioka O; Watanabe J; Keitoku M; Satoh S; Isoyama S; Ashikawa K; Ino-Oka E; Takishima T
    J Cardiovasc Pharmacol; 1986; 8(1):161-9. PubMed ID: 2419680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) and its solvent sulfolane on isolated heart preparations of the rat, guinea pig, and dog.
    Grupp G; Grupp IL; Newman G; Schwartz A
    Arzneimittelforschung; 1984; 34(3A):359-63. PubMed ID: 6540089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
    Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide modulates myocardial oxygen consumption in the failing heart.
    Chen Y; Traverse JH; Du R; Hou M; Bache RJ
    Circulation; 2002 Jul; 106(2):273-9. PubMed ID: 12105170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperosmotic mannitol on myocardial oxygen consumption.
    Vlahakes GJ; Powell WJ
    Am J Physiol; 1977 Oct; 233(4):H444-50. PubMed ID: 303055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.